BIIB - BIOGEN INC.
123.53
2.600 2.105%
Share volume: 1,460,071
Last Updated: 05-02-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$120.93
2.60
0.02%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 07-25-2023 | 11-08-2023 | 02-12-2025 | 04-24-2024 | 08-01-2024 | 10-30-2024 | 02-12-2025 | 05-01-2025 | |
| Total revenue | 2.456 B | 2.530 B | 2.386 B | 2.291 B | 2.465 B | 2.466 B | 2.455 B | 2.431 B | |
| Cost of revenue | 592.700 M | 659.600 M | 618.300 M | 542.200 M | 546.000 M | 638.700 M | 583.500 M | 629.300 M | |
| Gross profit | 1.863 B | 1.871 B | 1.768 B | 1.748 B | 1.919 B | 1.827 B | 1.871 B | 1.802 B | |
| 0.40% | -5.49% | -1.11% | 9.76% | -4.78% | 2.41% | -3.71% | |||
| Operating expenses | 1.132 B | 1.525 B | 1.179 B | 1.034 B | 1.068 B | 1.131 B | 1.212 B | 1.207 B | |
| Selling general and admin | 548.000 M | 788.200 M | 608.500 M | 581.500 M | 553.800 M | 588.400 M | 680.000 M | 572.500 M | |
| Research and development | 584.200 M | 736.300 M | 570.900 M | 452.900 M | 513.900 M | 542.700 M | 532.300 M | 634.800 M | |
| Total expenses | 1.155 B | 2.012 B | 1.161 B | 1.284 B | 1.220 B | 1.376 B | 1.236 B | 1.491 B | |
| 74.16% | -42.30% | 10.56% | -4.93% | 12.78% | -10.17% | 20.58% | |||
| Operating income | 708.100 M | -141.200 M | 607.100 M | 464.800 M | 698.700 M | 451.000 M | 635.100 M | 311.200 M | |
| Ebit | 708.100 M | -141.200 M | 607.100 M | 464.800 M | 698.700 M | 451.000 M | 635.100 M | 311.200 M | |
| Pretax income | 708.100 M | -141.200 M | 291.600 M | 464.800 M | 698.700 M | 451.000 M | 291.500 M | 311.200 M | |
| -119.94% | -306.52% | 59.40% | 50.32% | -35.45% | -35.37% | 6.76% | |||
| Income tax | 114.800 M | -72.900 M | 42.700 M | 71.400 M | 115.100 M | 62.500 M | 24.800 M | 70.700 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 593.300 M | -68.300 M | 248.900 M | 393.400 M | 583.600 M | 388.500 M | 266.700 M | 240.500 M | |
| -111.51% | 464.42% | 58.06% | 48.35% | -33.43% | -31.35% | -9.82% |
